Loading organizations...
Key people at Anthro Ventures.
Anthro Ventures was founded in 2017 by Omid Akhavan (Managing Director & Founder).
Anthro Ventures operates as a healthcare and life sciences investment firm, strategically deploying capital into companies poised to enhance patient outcomes while simultaneously driving down healthcare costs. The firm's approach emphasizes a deep understanding of the intricate context surrounding healthcare delivery, focusing on innovations, robust clinical research, and novel business models across medical devices, diagnostics, digital health, and healthcare services. They actively support their portfolio companies by providing crucial resources and fostering key relationships to accelerate their development.
Martin Omid Akhavan founded Anthro Ventures in 2017, driven by an insight into the necessity of humanizing healthcare investments. His vision stemmed from a belief that strategic capital, coupled with contextual understanding, could significantly transform medical practice. Akhavan brings a wealth of experience to this endeavor, having previously served as an Investment Principal at MVM Life Science Partners and as a Strategic Advisor at the McGeever Family Office, roles that honed his expertise in life sciences investment and strategic guidance.
The firm primarily partners with exceptional entrepreneurs and their companies across the healthcare ecosystem, including those developing medical devices, diagnostics, and digital health solutions. Anthro Ventures' ultimate vision is to contribute to a more effective healthcare system by addressing unmet clinical needs. They aspire to transform the practice of medicine through purposeful investments that lead to widespread benefits for patients, providers, and payers alike.
Anthro Ventures was founded in 2017 by Omid Akhavan (Managing Director & Founder).
Key people at Anthro Ventures.
Anthro Ventures has 2 tracked investments across 2 companies. The latest tracked deal is $5.2M Pre-Series A in twoplus fertility in May 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 9, 2022 | twoplus fertility | $5.2M Pre-Series A | — | Jack Wang, Golden Gate Ventures |
| Jan 1, 2020 | Ride Health | $6.0M Seed | Todd Pietri | BioAdvance, Foundry Group, Leading Edge Ventures, Newark Venture Partners, StartUp Health |